Replies to post #165906 on Cytodyn Inc (CYDY)

[stockorus]

Unless Cytodyn did not really include NEWS2 as a secondary endpoint for CD10.

"The National Early Warning Score (NEWS) is an objective scale developed by the Royal College of Physicians to identify patients at risk for rapid clinical deterioration requiring critical care intervention. NEWS2 (the latest version), is being used as an endpoint in several other COVID-19 clinical trials, including CytoDyn's severe-to-critical COVID-19 Phase 3 trial."

(https://www.cytodyn.com/newsroom/press-releases/detail/458/cytodyn-announces-clinically-significant-top-line-results)

Reading this, one wonders whether they are saying that for many other trials, NEWS2 is used as endpoint. And after noticing it succeeded in CD10, decided to informally tell us it was a (typical) secondary that was SS for us.

Otherwise I can't explain how FDA would make such a crucial error.

[misiu143]

Stockorus , you are right , I couldn't read to the end , if they left NEWS2 out , only that will win a case imo.

All imo.

[DonDonDonDon]

"written by lawyers so you may not sue them"

They did a bad job then, leaving out NEWS2 SS and saying CD10 failed in all secondary endpoints.

Or maybe Nader misrepresented the data. Ask yourself, has Nader ever been guilty of misrepresenting anything? Why is it that the CD10 trial results were never published?